- PR Newswire•2 days agoRoche receives FDA approval for fully automated blood screening assay on the cobas® 6800/8800 Systems
OTCQX: RHHBY) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for the cobas® MPX test for use on the cobas® 6800 and 8800 Systems. The cobas® MPX test enables donor screening laboratories to apply the most advanced PCR-based diagnostic technology to the surveillance of donated blood and plasma in the United States, preventing the spread of Human Immunodeficiency Virus Groups 1 and 2 (HIV-1 and HIV-2), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) through transfused blood products. "This approval reinforces our strong presence in donor screening, and underscores our ability to provide proven, robust technology for the testing of donated blood and blood products," said Uwe Oberlaender, Head of Roche Molecular Diagnostics.
- Zacks•2 days ago
Earnings season kicked off on a positive note for the pharma sector with J&J (JNJ) posting strong results.
Roche Holding AG (RHHBY)
Other OTC - Other OTC Delayed Price. Currency in USD
|Day's Range||29.14 - 29.28|
|52wk Range||29.14 - 35.13|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||21.96|
|Avg Vol (3m)||994,285|
|Dividend & Yield||1.02 (3.48%)|